Infinitopes

📍 Oxford, United Kingdom🗓 Founded 2021👥 30 employees💰 Last funded Nov 2022
Biotechnology Research
LinkedIn
Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Infinitopes?
Infinitopes has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Infinitopes last raise funding?
The most recent investment in Infinitopes recorded on gritt.io was in November 2022.
When was Infinitopes founded?
Infinitopes was founded in 2021.
What industry is Infinitopes in?
Infinitopes operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Infinitopes based?
Infinitopes is headquartered in Oxford, United Kingdom.